Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Clene Inc
(NQ:
CLNN
)
5.431
-0.129 (-2.32%)
Streaming Delayed Price
Updated: 11:57 AM EDT, Oct 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clene Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Analyst Scoreboard: 6 Ratings For Clene
May 23, 2024
Via
Benzinga
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Looking to Transform Healthcare for Individuals with Neurodegenerative Diseases
May 22, 2024
Via
Investor Brand Network
Study Identifies Genetic Link Between Parkinson’s, Inflammatory Bowel Disease
May 22, 2024
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024 Financial Results
May 21, 2024
Via
Investor Brand Network
The Analyst Verdict: Clene In The Eyes Of 5 Experts
April 17, 2024
Via
Benzinga
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Participation Schedule for Upcoming May Conferences
May 14, 2024
Via
Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 10, 2024
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!
Via
InvestorPlace
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation Highlights
May 08, 2024
Via
Investor Brand Network
Exposures
Product Safety
CLNN Stock Earnings: Clene Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
CLNN stock results show that Clene missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Speculative Penny Stocks Offering High-Upside Potential for Under a Buck
May 08, 2024
Although the concept of penny stocks under $1 is wildly speculative, these ideas could fly higher under the right circumstances.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
Study Suggests Metabolism Issues After Spinal-Cord Injury Result from Disturbed Neuronal Activity
May 03, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Spotlighted in a Recent ‘From Lab to Launch’ Podcast Release
May 01, 2024
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Presents Findings on Phase 2 VISIONARY-MS LTE at American Academy of Neurology Annual Meeting
May 01, 2024
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Continues Development of Lead Drug Candidate CNM Au8(R) for Neurodegenerative Diseases including Parkinson’s Disease
April 22, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
April 19, 2024
Via
Benzinga
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference
April 17, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 17, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 17, 2024
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!
Via
InvestorPlace
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
April 17, 2024
Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 16, 2024
Via
Benzinga
Study Identifies Three Distinct Subtypes of Multiple Sclerosis
April 15, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Looking to Advance Discussions for Accelerated Approval, New NDA for CNM-Au8(R) in 2024
April 11, 2024
Via
Investor Brand Network
Exposures
Product Safety
Clene Inc. (NASDAQ: CLNN) has Emerged as a Leader in the Neurodegenerative Field Utilizing a Novel Nanotherapeutic Drug
April 09, 2024
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Announces Publication of “Protein Corona Composition of Gold Nanocatalysts” in ACS Pharmacology & Translational Science
April 02, 2024
Via
Investor Brand Network
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Penny stocks are incredibly risky. However, if you can handle the heat, these ideas might be worth your while.
Via
InvestorPlace
Clene Inc. (NASDAQ: CLNN) Announces Operational Highlights for Lead Therapeutic Candidate for ALS and MS
March 26, 2024
Via
Investor Brand Network
New Study Leverages Real-World Data to Assess Differences in Parkinson’s Progression
March 25, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) Work in Nanotechnology Highlighted in ‘First in Human’ Podcast
March 19, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research for Investigational Drug CNM-Au8(R)
March 15, 2024
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.